Clinical Trial Update: Efficacy of Naltrexone HCl/Bupropion HCl Extended Release Versus Placebo for Treatment of Weight Regain in Participants Post Bariatric Surgery [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating naltrexone hydrochloride with bupropion hydrochloride extended-release versus placebo for weight regain after bariatric surgery was w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Naltrexone HCl/Bupropion HCl Extended Release (naltrexone hydrochloride / bupropion hydrochloride extended-release)

Snippet

Sponsor: Takeda | Conditions: Weight Regain Post Bariatric Surgery | Phase 4 | Status: WITHDRAWN